4//SEC Filing
Chardonnet Laurent 4
Accession 0001562180-22-008416
CIK 0001678660other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:05 PM ET
Size
5.6 KB
Accession
0001562180-22-008416
Insider Transaction Report
Form 4
Chardonnet Laurent
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-12-21+75,000→ 75,000 totalExercise: $4.90Exp: 2032-12-20→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on December 21, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001329010
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:05 PM ET
- Size
- 5.6 KB